21st Century Medicine has developed an entire platform
technology focused on the creation and commercialization of hypothermic
preservation and cryopreservation techniques, especially by vitrification.
These developments have taken science far beyond today’s
preservation limits. 21CM scientists have proven that long-term preservation
of complex living systems is possible.
So, what does all this mean?
It means that a vital link has been created in the biotechnology
supply chain.
Biopharmaceutical companies get a larger window in which
to test new drugs on viable tissue slices.
In assisted reproductive medicine, fertilization by safer,
less expensive and intensive methods is possible because damage to fragile
cells is minimized or totally eliminated.
And soon, organ banks can actually start banking
organs.
In fact, 21CM’s custom preservation protocols, solutions,
and devices support clients across a diverse range of natural and bio
artificial applications including everything from the natural survival
of Alaskan beetles to long-term storage of human corneas, and from revival
of Hawaiian coral to transportation of human skin cells.
From reliable and responsive contract research to innovative
process solutions, 21st Century Medicine can help resolve most time-sensitive
biologistical problems faced by researchers and producers of living
tissue products today.
21CM is currently working on applications in the following
areas:
Recent Articles:
[an error occurred while processing this directive]
Designing preservation systems to provide viable tissue slice
products in support of drug discovery platforms, lead optimization
technologies, and ADME/Toxicology studies.
Creating hypothermic solutions and protocols that better preserve
transplantable organs in a viable state between collection and
implantation while developing cryothermic vitrification protocols
that will eventually allow true cryogenic organ banking
Inventing ice-free cryopreservation methods that minimize or
eliminate damage to reproductive tissue while allowing for the
creation of human ova banks to mirror the sperm banks that have
been commonplace for many years.
